{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fpce.simplecast.com%2Fepisodes%2Fpodcast-2-ms-treatments-RjZ0LlFF","width":444,"version":"1.0","type":"rich","title":"Podcast 2: What’s New in Disease-Modifying Therapy","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/86952976-b928-4317-884c-2c7ba3b2ae4d/a41480d2-5a2a-44b2-bee9-a50e9d839bb1/pce-podcast-ms-pod636.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/47bcb967-0581-48c8-8247-54192439de04\" height=\"200\" width=\"100%\" title=\"Podcast 2: What’s New in Disease-Modifying Therapy\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this podcast, multiple sclerosis (MS) experts Stephen Krieger, MD and Allison Boyd, MPAS, PA-C, MSCS discuss current data supporting the use of the many available disease-modifying therapies for MS and the importance of shared decision-making in providing optimal care for patients. "}